Showing 991-1000 of 9846 results for "".
Inside LEVEL UP: Lead Investigator Discusses Upadacitinib Study
https://practicaldermatology.com/topics/atopic-dermatitis/inside-level-lead-investigator-discusses-upadacitinib-study/26661/Inside LEVEL UP: Lead Investigator Discusses Upadacitinib StudyInitiating Biologics
https://practicaldermatology.com/topics/psoriasis/initiating-biologics/19986/Kara S. Gooding, MMS, PA-C offers an overview of a panel discussion about initiating treatment with biologics. The panel shared real-world applications, plus tips on lab monitoring, managing side effects, and choosing the right biologic.Utilization of Sunscreen: An Interview with Dr. Murad Alam
https://practicaldermatology.com/topics/skin-cancer-photoprotection/utilization-of-sunscreen-an-interview-with-dr-murad-alam/26546/Utilization of Sunscreen: An Interview with Dr. Murad AlamTop 5 Skincare Trends on Social Media: What is Truly “Verified?”
https://practicaldermatology.com/issues/june-2024/top-5-skincare-trends-on-social-media-what-is-truly-verified/26556/Top 5 Skincare Trends on Social Media: What is Truly “Verified?”Scientifically Speaking: Investing in Innovation with Humberto Antunes
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-investing-in-innovation-with-humberto-antunes/20128/With decades of experience in dermatology and aesthetics, Humberto Antunes has helped to identify some key innovations in the field. Now part of Gore Range Capital, he continues to look for the next game-changer. He discusses his experience and shares insights on the specialties with host Joel L. CoPipeline Watch: Sizing Up a Promising Phase III IL-17 Biologic
https://practicaldermatology.com/topics/psoriasis/pipeline-watch-sizing-up-a-promising-phase-iii-il-17-biologic/21214/Pipeline Watch is a new Q&A feature appearing periodically in Practical Dermatology® that explores the potential of therapeutic agents currently under investigation. In each edition, we will speak with investigators from manufacturing companies to gain insights about the development and investigAbbVie's Skyrizi Approved, Brooke Shields Endorses SculpSure
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-abbvies-skyrizi-approved-brooke-shi/19607/Skyrizi, an interleukin-23 inhibitor from AbbVie, is FDA approved for the treatment of moderate to severe plaque psoriasis in adults. Brooke Shields is the face of the new “Be strong. Be sexy. Be confident” campaign for SculpSure, from Hologic’s Cynosure. The Noah Worcester Dermatological Society anSafe, Effective Treatments for Hair Loss
https://practicaldermatology.com/topics/hair-nails/safe-effective-treatments-for-hair-loss/26951/Safe, Effective Treatments for Hair LossOpportunities and Barriers in Teledermatology
https://practicaldermatology.com/conferences/aad-2021/opportunities-and-barriers-in-teledermatology/19923/Dermatologists' participation in telemedicine has increased exponentially over the past year. But what does the future hold? What opportunities exist and what challenges remain? Jules Lipoff, MD weighs in.EBD Insights
https://practicaldermatology.com/conferences/maui-derm-2022/ebd-insights/20049/There are a number of new and reliable energy-based devices available. Michael H. Gold, MD discusses tried-and-true technologies as well as new and innovative devices that offer efficacious options on the market for a variety of dermatologic needs.